Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
The New York Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding document that outlines the terms and conditions under which Gentling, Inc. obtains the rights to utilize certain collateral materials owned by The University of North Texas Health Science Center in the state of New York. This agreement governs the use, reproduction, distribution, and commercialization of the specified collateral materials, ensuring that both parties' interests and intellectual property rights are protected. In this agreement, Gentling, Inc. may have the opportunity to access and use a range of collateral materials owned by The University of North Texas Health Science Center, such as research findings, scientific data, patent applications, registered patents, trademarks, copyrights, proprietary information, and other related intellectual property. These materials may be crucial for Gentling's research, development, manufacturing, marketing, and sales activities. The New York Collateral License Agreement is designed to delineate the specific rights and restrictions associated with the use of the collateral materials. It typically covers areas such as confidentiality, ownership, licensing fees or royalties, termination clauses, dispute resolution mechanisms, compliance with applicable laws and regulations, and any additional terms agreed upon by the parties involved. Types of New York Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may vary depending on the purpose and scope of the collateral materials involved. Here are a few examples: 1. Research Collaboration Agreement: This type of agreement may enable Gentling, Inc. to collaborate with The University of North Texas Health Science Center on specific research projects, allowing access to collateral materials related to ongoing studies and findings. The agreement may cover joint ownership of intellectual property developed during the collaboration, sharing of financial responsibilities, and publication rights. 2. Intellectual Property License Agreement: In this type of agreement, Gentling, Inc. may be granted a license to use specific collateral materials owned by The University of North Texas Health Science Center for a defined purpose, such as incorporating patented technology or copyrighted information into their products, services, or research. The agreement may establish licensing fees, duration, and any restrictions on the use or transfer of the licensed materials. 3. Material Transfer Agreement: This agreement governs the transfer of tangible materials, such as biological samples, research tools, or proprietary cell lines, from The University of North Texas Health Science Center to Gentling, Inc. The agreement defines the purpose of the transfer, any restrictions on use, responsibility for shipping and handling, and ownership of any derived intellectual property. These examples represent common types of Collateral License Agreements that may occur between Gentling, Inc. and The University of North Texas Health Science Center in the context of research, innovation, and intellectual property collaboration within the state of New York.
The New York Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding document that outlines the terms and conditions under which Gentling, Inc. obtains the rights to utilize certain collateral materials owned by The University of North Texas Health Science Center in the state of New York. This agreement governs the use, reproduction, distribution, and commercialization of the specified collateral materials, ensuring that both parties' interests and intellectual property rights are protected. In this agreement, Gentling, Inc. may have the opportunity to access and use a range of collateral materials owned by The University of North Texas Health Science Center, such as research findings, scientific data, patent applications, registered patents, trademarks, copyrights, proprietary information, and other related intellectual property. These materials may be crucial for Gentling's research, development, manufacturing, marketing, and sales activities. The New York Collateral License Agreement is designed to delineate the specific rights and restrictions associated with the use of the collateral materials. It typically covers areas such as confidentiality, ownership, licensing fees or royalties, termination clauses, dispute resolution mechanisms, compliance with applicable laws and regulations, and any additional terms agreed upon by the parties involved. Types of New York Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center may vary depending on the purpose and scope of the collateral materials involved. Here are a few examples: 1. Research Collaboration Agreement: This type of agreement may enable Gentling, Inc. to collaborate with The University of North Texas Health Science Center on specific research projects, allowing access to collateral materials related to ongoing studies and findings. The agreement may cover joint ownership of intellectual property developed during the collaboration, sharing of financial responsibilities, and publication rights. 2. Intellectual Property License Agreement: In this type of agreement, Gentling, Inc. may be granted a license to use specific collateral materials owned by The University of North Texas Health Science Center for a defined purpose, such as incorporating patented technology or copyrighted information into their products, services, or research. The agreement may establish licensing fees, duration, and any restrictions on the use or transfer of the licensed materials. 3. Material Transfer Agreement: This agreement governs the transfer of tangible materials, such as biological samples, research tools, or proprietary cell lines, from The University of North Texas Health Science Center to Gentling, Inc. The agreement defines the purpose of the transfer, any restrictions on use, responsibility for shipping and handling, and ownership of any derived intellectual property. These examples represent common types of Collateral License Agreements that may occur between Gentling, Inc. and The University of North Texas Health Science Center in the context of research, innovation, and intellectual property collaboration within the state of New York.